Every little bit helps: A single-residue switch in a vascular AAV enables blood-brain barrier penetration

• Dirk Grimm,
• Mathieu Nonnenmacher

Affiliations

Dirk Grimm

Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, BioQuant, Heidelberg University, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany

Mathieu Nonnenmacher

Voyager Therapeutics, 64 Sidney Street, Cambridge, MA 02139, USA; Corresponding author: Mathieu Nonnenmacher, Voyager Therapeutics, 64 Sidney Street, Cambridge, MA 02139, USA.